Filing Details

Accession Number:
0001178913-18-002034
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-03 16:09:26
Reporting Period:
2018-07-02
Accepted Time:
2018-07-03 16:09:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1606645 Foamix Pharmaceuticals Ltd. FOMX Medicinal Chemicals & Botanical Products (2833) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1727794 David Domzalski C/O Foamix Pharmaceuticals Ltd.
2 Holtzman Street
Rehovot L3 7670402
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2018-07-02 602 $5.10 162,481 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of re-stricted share units. This sale is mandated by the Issuer's non-discretionary policy that requires the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.